Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.6.6 is now shown, replacing v3.6.5. This indicates an internal page or template update rather than any changes to the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, signaling a minor deployment update to the page. This update does not alter the study details or other content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision label updated from v3.6.3 to v3.6.4, indicating a new build/maintenance update of the ClinicalTrials.gov page. This update does not alter the study content or data displayed.SummaryDifference0.1%

- Check72 days agoChange DetectedFooter revision tag updated from v3.6.2 to v3.6.3, indicating a minor page update. No study information or functionality is affected.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page now displays a newer revision tag (v3.6.2) replacing the previous v3.6.0, indicating a software/system update for the page.SummaryDifference0.1%

- Check93 days agoChange DetectedAdded help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and a Revision: v3.6.0 notice. The 'Intervention / Treatment' label was reformatted to 'Intervention/Treatment' and the older 'Revision: v3.5.5' note was removed.SummaryDifference0.5%

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.